CARLSMED

San Diego, United States Founded: 2018 • Age: 8 yrs
Developer of devices for spine surgery
Request Access

About CARLSMED

CARLSMED is a company based in San Diego (United States) founded in 2018 by Mike Cordonnier and Niall Casey.. CARLSMED has raised $109.63 million across 6 funding rounds from investors including B Capital, USVP and The Vertical Group. The company has 59 employees as of December 31, 2023. CARLSMED offers products and services including aprevo and myaprevo. CARLSMED operates in a competitive market with competitors including Stryker, NuVasive, In'Tech Medical, Orthofix and Zavation, among others.

  • Headquarter San Diego, United States
  • Employees 59 as on 31 Dec, 2023
  • Founders Mike Cordonnier, Niall Casey
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Carlsmed, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $109.63 M (USD)

    in 6 rounds

  • Latest Funding Round
    $64.5 M (USD), Series C

    Mar 12, 2024

  • Investors
    B Capital

    & 6 more

  • Employee Count
    59

    as on Dec 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of CARLSMED

CARLSMED is a publicly listed company on the NASDAQ with ticker symbol CARL in USA, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: CARL . Sector: Technology services · USA

Products & Services of CARLSMED

CARLSMED offers a comprehensive portfolio of products and services, including aprevo and myaprevo. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Platform for personalized spine surgery planning and execution

Tool for 3D visualization in spinal care procedures

People of CARLSMED
Headcount 10-50
Employee Profiles 25
Board Members and Advisors 4
Employee Profiles
People
Mallorie Lotycz Rauch, MCMSc, PA-C
Manager Professional Education
People
Thomas Lopez
Senior Director Medical Education
People
Niall Casey
Chief Technology Officer
People
Mike Cordonnier
CEO

Unlock access to complete

Board Members and Advisors
people
Robert Mittendorf
Director

Unlock access to complete

Funding Insights of CARLSMED

CARLSMED has successfully raised a total of $109.63M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $64.5 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round Series C — $64.5M
  • First Round
  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2024 Amount Series C - CARLSMED Valuation B Capital , USVP
Apr, 2022 Amount Series B - CARLSMED Valuation B Capital
Dec, 2020 Amount Series A - CARLSMED Valuation USVP
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in CARLSMED

CARLSMED has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include B Capital, USVP and The Vertical Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Multistage investments are directed toward technology, healthcare, and climate sectors.
Founded Year Domain Location
VC firm that focuses on early stage investments in the US
Founded Year Domain Location
Investments in early and late-stage US companies are made.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by CARLSMED

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - CARLSMED

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Carlsmed Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of CARLSMED

CARLSMED operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Stryker, NuVasive, In'Tech Medical, Orthofix and Zavation, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
3D-printed orthopedic products are manufactured for medical applications.
domain founded_year HQ Location
Smart surgical devices for spinal surgery are developed.
domain founded_year HQ Location
Surgical instruments for orthopaedics are developed and manufactured.
domain founded_year HQ Location
Reconstructive and regenerative solutions for bone conditions are developed.
domain founded_year HQ Location
Medical devices for spine surgery are designed, manufactured, and distributed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Carlsmed

Frequently Asked Questions about CARLSMED

When was CARLSMED founded?

CARLSMED was founded in 2018 and raised its 1st funding round 1 year after it was founded.

Where is CARLSMED located?

CARLSMED is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Who is the current CEO of CARLSMED?

Mike Cordonnier is the current CEO of CARLSMED. They have also founded this company.

Is CARLSMED a funded company?

CARLSMED is a funded company, having raised a total of $109.63M across 6 funding rounds to date. The company's 1st funding round was a Series A of $12.63M, raised on Jun 05, 2019.

How many employees does CARLSMED have?

As of Dec 31, 2023, the latest employee count at CARLSMED is 59.

What does CARLSMED do?

Founded in 2018 and based in San Diego, United States, CARLSMED operates in the medical device sector. Patient data and proprietary digital technologies are utilized to generate surgical plans and personalized Aprevo spine fusion devices. These are designed for adult spinal malalignment cases, with operations focused on optimizing spine surgery outcomes through customized solutions.

Who are the top competitors of CARLSMED?

CARLSMED's top competitors include Stryker, NuVasive and In'Tech Medical.

What products or services does CARLSMED offer?

CARLSMED offers aprevo and myaprevo.

Is CARLSMED publicly traded?

Yes, CARLSMED is publicly traded on NASDAQ under the ticker symbol CARL.

Who are CARLSMED's investors?

CARLSMED has 7 investors. Key investors include B Capital, USVP, The Vertical Group, Cove Fund, and Wavemaker 360.

What is CARLSMED's ticker symbol?

The ticker symbol of CARLSMED is CARL on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available